Cardiomyopathy as indication for pediatric heart transplantation
Pediatric cardiomyopathy (CMP), with an incidence of approximately 1 in 100,000 children, remains a critical clinical challenge. Often progressive, these myocardial disorders frequently culminate in end-stage heart failure, establishing CMP as the primary indication for pediatric heart transplantati...
Saved in:
| Main Authors: | Alireza Raissadati, MD/PHD, Drishti Tolani, MD, Elizabeth L. Profita, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-11-01
|
| Series: | JHLT Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950133425001557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal
by: Lina Manzi, et al.
Published: (2025-02-01) -
Hypertrophic obstructive cardiomyopathy in a heart transplant recipient: a case report
by: G. A. Golovina, et al.
Published: (2021-10-01) -
Similar burden of rare genetic variants in ischemic and non-ischemic dilated cardiomyopathy
by: Louie Cao, et al.
Published: (2025-04-01) -
Heart transplantation in secondary dilated cardiomyopathy due to myocarditis. Case report
by: D. V. Romashova, et al.
Published: (2023-06-01) -
Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case
by: M. R. Zaynetdinov, et al.
Published: (2022-07-01)